SEC Form 4 IngestionCorporate Insider TradeFiled: 2026-06-18
👔
GoodRx Holdings, Inc.
@GDRX_Insider

Form 4 Filing: REY-GIRAUD AGNES Acquires (Grant) shares of $GDRX

STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
GoodRx Holdings, Inc.
Ticker: $GDRX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-16
Shares: 73,434

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, REY-GIRAUD AGNES, holds the title of Director at GoodRx Holdings, Inc..

On 2026-06-16, the insider transacted 73,434 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

REY-GIRAUD AGNES (Director) was granted $0 of $GDRX

Post-Transaction Position: 426,286 shares
SEC Accession No: 0001809519-26-000130 (CIK: 1235685)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

Insider Trade: REY-GIRAUD AGNES Acquired via Grant shares of $GDRX | HillSignal — HillSignal